Compare Wegovy vs Mounjaro Mechanisms And Private Access
What Is The Difference Between Wegovy And Mounjaro Private Prescription Routes?
When considering what is the difference between Wegovy and Mounjaro through private prescription, the most significant advantage is bypassing NHS waiting lists entirely. The NHS route requires GP referral to specialist weight management services, often involving 6+ month waiting periods before accessing either treatment. Our private prescription service eliminates these delays through a streamlined 3-minute online clinical assessment. Both Wegovy and Mounjaro are available from EverydayMeds — your prescriber can help determine which is right for you based on your clinical history and treatment goals.
The private route provides identical medications to those prescribed through NHS services, manufactured by the same pharmaceutical companies (Novo Nordisk for Wegovy, Eli Lilly for Mounjaro). Our GPhC-registered pharmacy (#9012878) ensures the same quality standards and cold-chain delivery that maintains medication efficacy. Private prescription also offers greater flexibility in dose adjustments and ongoing support, without the restrictive criteria often applied in NHS specialist clinics.
Understanding What Is The Difference Between Wegovy And Mounjaro Pricing Through Private Access
Wegovy pricing starts at £79.99 for the 0.25mg starter dose using code FIRST40 for new customers, progressing through £94.99 (0.5mg), £99.99 (1mg), £139.99 (1.7mg), to £209.99 for the 2.4mg maintenance dose. Our Getting Started bundles provide convenient dose progression, such as the Intro Duo (0.25mg & 0.5mg) for £169.99. Returning customers benefit from code DOSE25 applied at checkout. The Ultimate Stability Trio provides three months of 2.4mg maintenance supply for £649.99, ensuring treatment continuity without repeated ordering.
Mounjaro follows a different pricing structure due to its newer market entry and dual-agonist formulation. Both treatments represent prescription-only medicines requiring clinical assessment and ongoing monitoring. The cost comparison should factor in the convenience of private access, eliminating travel to specialist clinics and time off work for appointments. Payment plans and bundle options make both treatments accessible whilst ensuring uninterrupted supply during your weight management journey.
What Is The Difference Between Wegovy And Mounjaro Clinical Evidence Base?
Wegovy's clinical evidence derives from the comprehensive STEP trial programme, with STEP 1 demonstrating approximately 15% average weight loss at 68 weeks versus 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events. In clinical trials, patients taking Wegovy alongside diet and exercise achieved sustained weight management over extended periods.
Mounjaro's evidence comes from the SURMOUNT trial series, showing the dual GIP and GLP-1 receptor agonist mechanism. However, comparing trial weight loss percentages directly between treatments isn't appropriate due to different trial designs, patient populations, and endpoints. Both medications work through appetite regulation and satiety enhancement, though their receptor targeting differs significantly in approach and potential side effect profiles.
How Wegovy Works Compared To Mounjaro's Dual Mechanism
Understanding what is the difference between Wegovy and Mounjaro requires examining their distinct mechanisms of action at the cellular level. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics the natural incretin hormone released after eating. This hormone signals satiety to the brain, reduces appetite, and may help control food cravings by acting on appetite centres in the hypothalamus. The GLP-1 pathway also slows gastric emptying, prolonging the feeling of fullness after smaller meals. Wegovy's once-weekly injection maintains consistent semaglutide levels, providing sustained appetite regulation throughout the treatment period.
Streamlined Ordering Process For Both Wegovy And Mounjaro Private Prescriptions
Our ordering process eliminates the complexity of NHS referral pathways through a straightforward three-step approach. Complete the 3-minute online clinical assessment covering medical history, current medications, and weight management goals. Qualified prescribers review applications within standard 3 working days, or 24 hours with express service. Once approved, both Wegovy and Mounjaro ship via next-day delivery using temperature-controlled cold-chain packaging to maintain medication stability. The process includes ongoing support and dose adjustment guidance from our clinical team. All communications remain confidential, and repeat prescriptions can be processed seamlessly through your online account.
Storage Advantages: What Is The Difference Between Wegovy And Mounjaro Stability?
Storage requirements highlight a practical difference between these treatments, particularly for frequent travellers or those with limited refrigeration access. Wegovy demonstrates superior room temperature stability, maintaining efficacy for up to 6 weeks below 30°C once removed from refrigeration, compared to Mounjaro's 21-day room temperature limit. Both require initial storage at 2-8°C in the refrigerator. Wegovy's FlexTouch pen delivery system provides precise dose administration with clear dosing windows, whilst both treatments follow mandatory dose escalation schedules to minimise gastrointestinal side effects. The extended room temperature stability of Wegovy offers significant advantages for business travel, holidays, or temporary refrigeration issues.
Private Prescription Benefits: What Is The Difference Between Wegovy And Mounjaro NHS Access?
Private prescription access transforms the patient experience compared to NHS pathways for both treatments. NHS criteria often restrict access to patients with BMI ≥35 plus comorbidities, whilst private assessment considers individual circumstances more flexibly. Specialist NHS clinics may have limited appointment availability and geographical constraints, particularly affecting rural patients. Private prescription eliminates these barriers whilst maintaining identical safety standards and clinical oversight.
The ongoing support model differs significantly, with private services offering direct access to prescribing clinicians rather than navigating NHS appointment booking systems. Dose adjustments, side effect management, and treatment modifications can be addressed promptly through secure messaging or telephone consultations. This responsive approach proves particularly valuable during the initial dose escalation phase when patients may experience temporary side effects requiring clinical guidance.
Choose Your Treatment With Expert Clinical Support And Next-Day Delivery
Both Wegovy and Mounjaro are available through our comprehensive private prescription service, providing expert clinical assessment and ongoing support throughout your weight management journey. New customers apply code FIRST40 at checkout, whilst returning customers use DOSE25 for continued access to competitive pricing. Our GPhC-registered pharmacy (#9012878) ensures pharmaceutical-grade quality and cold-chain delivery maintaining treatment efficacy. Complete your clinical assessment today to discover which treatment aligns with your health goals and lifestyle requirements. Visit our secure ordering platform to begin your assessment and connect with qualified prescribers who can guide your treatment selection based on clinical evidence and individual needs.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
